These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29241014)

  • 1. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Cisatracurium Compared to Vecuronium for Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Vallabh P; Ha M; Ahern K
    J Intensive Care Med; 2023 Feb; 38(2):188-195. PubMed ID: 35821572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.
    Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K
    J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
    Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
    Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Cisatracurium the Neuromuscular Blocking Agent of Choice in Acute Respiratory Distress Syndrome?
    Huang DT; Papazian L
    Am J Respir Crit Care Med; 2018 Apr; 197(7):849-850. PubMed ID: 29324189
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
    Riley K; Yampolsky N; Hakma Z; Moussouttas M
    Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended neuromuscular blockade in acute respiratory distress syndrome does not increase mortality.
    Barmparas G; Dhillon NK; Tatum JM; Patel K; Thomsen GM; Mason R; Margulies DR; Ley EJ
    J Surg Res; 2018 Nov; 231():434-440. PubMed ID: 30278965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.